During more than a century of business, US agrochemical colossus Monsanto has been vilified for products critics say harm people and the environment.
In the first trial of its kind, a Californian dying of cancer is suing Monsanto, claiming its popular herbicide Roundup caused his disease -- a case that could have sweeping ramifications.
A jury today is scheduled to begin hearing pitches from opposing sides, with witnesses to follow.
The stakes are high for Monsanto, which could face massive losses should a jury order it to pay out damages over the product, whose main ingredient is glyphosate, a substance some say is dangerously carcinogenic.
Dewayne Johnson, a 46-year-old father of two, says he is sick because of contact with Roundup, which he used for two years from 2012 as a groundskeeper for the Benicia school district near San Francisco, his lawyer Timothy Litzenburg told AFP.
"A major part of that job was spraying Roundup or Ranger Pro (a similar Monsanto product).... He sprayed it 20 to 40 times per year, sometimes hundreds of gallons at a time on the school properties," Litzenburg said.
In 2014, Johnson was diagnosed with non-Hodgkin's lymphoma, a cancer that affects white blood cells. No longer able to work two years later, he filed suit against Monsanto, accusing the company of hiding the dangers of its product.
A key to Johnson's case will be convincing jurors that Monsanto's pesticide is to blame for his illness.
"His case has been expedited because he currently has only a few months to live," his lawyer said.
Litzenburg says he represents hundreds of people who also say they are victims of glyphosate.
Whether the substance causes cancer has been the source of endless debate among government regulators, health experts and lawyers.
Monsanto, a company that is more than a century old, was recently acquired by Germany-based Bayer for more than $62 billion.
Founded in 1901 in St. Louis, Missouri, Monsanto made the artificial sweetener saccharin. The company began producing agrochemicals in the 1940s and now employs 20,000 people around the world and generates $15 billion in annual revenue.
Monsanto was one of the companies which produced a defoliant dubbed "Agent Orange," which has been linked to cancer and other diseases, for use by US forces in Vietnam but denies responsibility for how the military used it. The company also made insecticide DDT.
Monsanto's flagship herbicide Roundup was launched in 1976.
The company soon thereafter began genetically modifying plants, making some resistant to Roundup.
The pesticide has been accused of damaging the environment, contributing to the disappearance of bees and being an endocrine disruptor.
The Roundup trial in San Francisco, which will directly address whether product has caused cancer, is the first of its kind.
The International Agency for Research on Cancer, a World Health Organization body, has classified glyphosate, which is widely used around the world, as "probably carcinogenic." The European food safety and chemicals agencies have so far not followed suit. A US Department of Health study has suggested its toxicity is limited.
Monsanto has always denied any link between disease and glyphosate, a substance classified as carcinogenic in the state of California.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
